Cargando…

Network pharmacology analysis and experimental validation to explore the mechanism of Bushao Tiaozhi capsule (BSTZC) on hyperlipidemia

Bushao Tiaozhi Capsule (BSTZC) is a novel drug in China that is used in clinical practice and has significant therapeutic effects on hyperlipidemia (HLP). In our previous study, BSTZC has a good regulatory effect on lipid metabolism of HLP rats. However, its bioactive compounds, potential targets, a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiao, Guanlin, Zeng, Zhihao, Jiang, Jieyi, Xu, Aili, Li, Sumei, Li, Yangxue, Chen, Zhao, Chen, Weitao, Zhang, Jingnian, Bi, Xiaoli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9051129/ https://www.ncbi.nlm.nih.gov/pubmed/35484204 http://dx.doi.org/10.1038/s41598-022-11139-2

Ejemplares similares

Metabolomics analysis delineates the therapeutic effects of Yinlan Tiaozhi capsule on triton WR-1339 -induced hyperlipidemia in mice
por: Xiao, Guanlin, et al.
Publicado: (2023)

Deciphering the mechanisms of Yinlan Tiaozhi capsule in treating hyperlipidemia by combining network pharmacology, molecular docking and experimental verification
por: Xiao, Guanlin, et al.
Publicado: (2023)

Network Pharmacology and Molecular Docking-Based Prediction of the Mechanism of Qianghuo Shengshi Decoction against Rheumatoid Arthritis
por: Zeng, Zhihao, et al.
Publicado: (2021)

Long-Term Effect of Zhenzhu Tiaozhi Capsule (FTZ) on Hyperlipidemia: 2-Year Results from a Retrospective Study Using Electronic Medical Records
por: Huang, Xiaoqiang, et al.
Publicado: (2021)

Fufang-Zhenzhu-Tiaozhi Capsule reduces restenosis via the downregulation of NF-kappaB and inflammatory factors in rabbits
por: Zhang, Rendan, et al.
Publicado: (2018)

Fufang Zhenzhu Tiaozhi Capsule Prevents Intestinal Inflammation and Barrier Disruption in Mice With Non-Alcoholic Steatohepatitis
por: Lan, Tian, et al.
Publicado: (2022)

Effects of Tiaozhi Granule on Regulation of Autophagy Levels in HUVECs
por: Wu, Ying-Ying, et al.
Publicado: (2018)

Traditional Chinese Medicine Fufang-Zhenzhu-Tiaozhi capsule prevents renal injury in diabetic minipigs with coronary heart disease
por: Song, Lixia, et al.
Publicado: (2022)

Modulation of the Gut Microbiota by Fufang-Zhenzhu-Tiaozhi Capsule Attenuates Hypertension Induced by a High-Fructose and High-Salt Diet
por: Chen, Zhe, et al.
Publicado: (2022)

Analysis of the Constituents in Rat Serum after Oral Administration of Fufang Zhenzhu Tiaozhi Capsule by UPLC–Q–TOF–MS/MS
por: Zhong, Xunlong, et al.
Publicado: (2011)

Study on Metabolic Trajectory of Liver Aging and the Effect of Fufang Zhenzhu Tiaozhi on Aging Mice
por: Luo, Duosheng, et al.
Publicado: (2019)

The therapeutic effect of Fufang Zhenshu Tiaozhi (FTZ) on osteoclastogenesis and ovariectomized-induced bone loss: evidence from network pharmacology, molecular docking and experimental validation
por: Chen, Xiaojun, et al.
Publicado: (2022)

Exploration of the Modulatory Property Mechanism of ELeng Capsule in the Treatment of Endometriosis Using Transcriptomics Combined With Systems Network Pharmacology
por: Zheng, Weilin, et al.
Publicado: (2021)

Untargeted Metabolomics Reveals the Protective Effect of Fufang Zhenshu Tiaozhi (FTZ) on Aging-Induced Osteoporosis in Mice
por: Luo, Duosheng, et al.
Publicado: (2019)

Exploring the Regulation of Jiangtang Tiaozhi Formula on the Biological Network of Obese T2DM Complicated With Dyslipidemia Based on Clinical Transcriptomics
por: Bao, Tingting, et al.
Publicado: (2022)

The Target MicroRNAs and Potential Underlying Mechanisms of Yiqi-Bushen-Tiaozhi Recipe against‐Non-Alcoholic Steatohepatitis
por: Hong, Wei, et al.
Publicado: (2020)

The Efficacy and Safety of Chinese Medicine Fufang Zhenzhu Tiaozhi Capsule (FTZ) in the Treatment of Diabetic Coronary Heart Disease: Study Protocol for Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial
por: Wang, Lexun, et al.
Publicado: (2021)

Pharmacological treatment of hypertension and hyperlipidemia in Izhevsk, Russia
por: Cybulsky, Marta, et al.
Publicado: (2016)

The Potential Mechanism of Wuwei Qingzhuo San against Hyperlipidemia Based on TCM Network Pharmacology and Validation Experiments in Hyperlipidemia Hamster
por: Li, Jianliang, et al.
Publicado: (2020)

Effects of Extracts from Tiaozhi Granule and Its Components on Expression of Scavenger Receptor Class B Type I
por: Yu, Xiao, et al.
Publicado: (2016)

Integrated lipidomics and network pharmacology analysis to reveal the mechanisms of berberine in the treatment of hyperlipidemia
por: Chen, Yuting, et al.
Publicado: (2022)

Naoxintong Capsule Alternates Gut Microbiota and Prevents Hyperlipidemia in High-Fat-Diet Fed Rats
por: Lu, Yihang, et al.
Publicado: (2022)

Yiqi-Bushen-Tiaozhi Recipe Attenuated High-Fat and High-Fructose Diet Induced Nonalcoholic Steatohepatitis in Mice via Gut Microbiota
por: Yan, Junbin, et al.
Publicado: (2022)

Shuangyu Tiaozhi Granule Attenuates Hypercholesterolemia through the Reduction of Cholesterol Synthesis in Rat Fed a High Cholesterol Diet
por: Shi, Jingjing, et al.
Publicado: (2019)

Metabolomic and Microbial Remodeling by Shanmei Capsule Improves Hyperlipidemia in High Fat Food-Induced Mice
por: Du, Lijing, et al.
Publicado: (2022)

Efficacy and Mechanism of the Jiangtang Tiaozhi Recipe in the Management of Type 2 Diabetes and Dyslipidaemia: A Clinical Trial Protocol
por: Wu, Haoran, et al.
Publicado: (2022)

Comprehensive multiomics analysis of the effect of ginsenoside Rb1 on hyperlipidemia
por: Lianqun, Jia, et al.
Publicado: (2021)

The Mechanism of Dendrobium officinale as a Treatment for Hyperlipidemia Based on Network Pharmacology and Experimental Validation
por: Li, Lin-Zi, et al.
Publicado: (2022)

Shuangyu Tiaozhi decoction alleviates non-alcoholic fatty liver disease by improving lipid deposition, insulin resistance, and inflammation in vitro and in vivo
por: Yin, Guoliang, et al.
Publicado: (2022)

Investigation of the Lipid-Lowering Mechanisms and Active Ingredients of Danhe Granule on Hyperlipidemia Based on Systems Pharmacology
por: Chen, Kuikui, et al.
Publicado: (2020)

Based on Network Pharmacology and RNA Sequencing Techniques to Explore the Molecular Mechanism of Huatan Jiangzhuo Decoction for Treating Hyperlipidemia
por: Zhou, Xiaowen, et al.
Publicado: (2021)

Herbal medicine formula Huazhuo Tiaozhi granule ameliorates dyslipidaemia via regulating histone lactylation and miR-155-5p biogenesis
por: Yin, Xiangjun, et al.
Publicado: (2023)

Exploring the pharmacological mechanism of Shengjing capsule on male infertility by a network pharmacology approach
por: Wang, Ming, et al.
Publicado: (2022)

Hyperlipidemia Is a Risk Factor of Adhesive Capsulitis: Real-World Evidence Using the Taiwanese National Health Insurance Research Database
por: Wang, Jr-Yi, et al.
Publicado: (2021)

Efficacy and safety of Yirui capsule in patients with hyperlipidemia: study protocol for a multicenter, randomized, double-blind, placebo-controlled trial
por: Dai, Liang, et al.
Publicado: (2016)

Exploring the Molecular Mechanism of Action of Yinchen Wuling Powder for the Treatment of Hyperlipidemia, Using Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation
por: Ye, Jiahao, et al.
Publicado: (2021)

The Pharmacological Mechanism of Guchangzhixie Capsule Against Experimental Colitis
por: Yan, Jing, et al.
Publicado: (2021)

Exploring the Mechanism of Action Compound-Xueshuantong Capsule in Diabetic Retinopathy Treatment Based on Network Pharmacology
por: Li, Haoran, et al.
Publicado: (2020)

Zhilong Huoxue Tongyu capsule inhibits rabbit model of hyperlipidemia and atherosclerosis through NF-κB/NLRP3 signaling pathway
por: Liu, Mengnan, et al.
Publicado: (2023)

Monogenic hyperlipidemias
por: Krasi, Geraldo, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_dp2v3gibc06q8naa7qibr3oo1a